Randomised double-blind trial of megestrol acetate vs placebo in treatment-naive advanced hepatocellular carcinoma

Pierce K. H. Chow,David Machin,Chen Y,Zhang X,Khin Maung Win,Hoang Hh,Nguyen Bd,Jin My,Rolley Rey Lobo,Michael Findlay,Lim Ch,Say Beng Tan,Mihir Gandhi,Khee Chee Soo

Randomised double-blind trial of megestrol acetate vs placebo in treatment-naive advanced hepatocellular carcinoma

2011

Pierce K. H. Chow
David Machin
Chen Y
Zhang X
Khin Maung Win
Hoang Hh
Nguyen Bd
Jin My
Rolley Rey Lobo
Michael Findlay
Lim Ch
Say Beng Tan
Mihir Gandhi
Khee Chee Soo

Background: Hepatocellular carcinoma (HCC) is the third leading cause of cancer deaths worldwide. We tested megestrol acetate (MA) against placebo in the treatment of advanced HCC.

Keywords:

Medicine
Pathology
Cancer
Megestrol acetate
Placebo
Hepatocellular carcinoma
Survival rate
Young adult
double blind
therapy naive

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations